Difference in normal limit values of nerve conduction parameters between Westerners and Japanese people might need to be considered when diagnosing diabetic polyneuropathy using a Point-of-Care Sural Nerve Conduction Device (NC-stat®/DPNCheck)

被引:20
作者
Hirayasu, Kazuhiro [1 ]
Sasaki, Hideyuki [1 ]
Kishimoto, Shohei [1 ]
Kurisu, Seigo [1 ]
Noda, Koji [1 ]
Ogawa, Kenichi [1 ]
Tanaka, Hiroto [1 ]
Sakakibara, Yumiko [1 ]
Matsuno, Shohei [1 ]
Furuta, Hiroto [1 ]
Arita, Mikio [1 ]
Naka, Keigo [1 ]
Nanjo, Kishio [1 ]
机构
[1] Wakayama Med Univ, Kihoku Hosp, Dept Med, Wakayama, Japan
基金
日本学术振兴会;
关键词
Clinical; Complication I - nerve; Diagnosis and pathophysiology; SENSORIMOTOR POLYNEUROPATHY; HEIGHT;
D O I
10.1111/jdi.12818
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Aim/IntroductionStudies on a novel point-of-care device for nerve conduction study called DPNCheck have been limited to Westerners. We aimed to clarify Japanese normal limits of nerve action potential amplitude (Amp) and conduction velocity by DPNCheck (investigation I), and the validity of DPNCheck to identify diabetic symmetric sensorimotor polyneuropathy (DSPN; investigation II). Materials and MethodsFor investigation I, 463 non-neuropathic Japanese participants underwent DPNCheck examinations. Regression formulas calculating the normal limits of Amp and conduction velocity (Japanese regression formulas [JRF]) were determined by quantile regression and then compared with regression formulas of individuals from the USA (USRF). For investigation II, in 92 Japanese diabetes patients, probable DSPN' was diagnosed and nerve conduction abnormalities (NCA1: one or more abnormalities, and NCA2: two abnormalities in Amp and conduction velocity) were determined. Validity of NCAs to identify probable DSPN' was evaluated by determining sensitivity, specificity, reproducibility (kappa-coefficient) and the area under the curve of receiver operating characteristic curves. ResultsFor investigation I, JRF was different from USRF, and normal limits by JRF were higher than that of USRF. The prevalence of Amp abnormality calculated by JRF was significantly higher than that of USRF. For investigation II, the sensitivity, specificity and reproducibility of NCA1 and NCA2 judged from JRF were 85%, 86% and 0.57, and 43%, 100% and 0.56, respectively. These values of JRF were higher than those of USRF. The area under the curve of JRF (0.89) was larger than USRF (0.82). ConclusionsA significant difference in the normal limits of nerve conduction parameters by DPNCheck between Japanese and USA individuals was suggested. Validity to identify DSPN of NCAs might improve by changing the judgment criteria from USRF to JRF.
引用
收藏
页码:1173 / 1181
页数:9
相关论文
共 13 条
[1]   Association of nerve conduction impairment and insulin resistance in children with obesity [J].
Akin, Onur ;
Eker, Ibrahim ;
Arslan, Mutluay ;
Tasdemir, Serdar ;
Tascilar, Mehmet Emre ;
Ulas, Umit Hidir ;
Yesilkaya, Ediz ;
Unay, Bulent .
CHILDS NERVOUS SYSTEM, 2016, 32 (11) :2219-2224
[2]   INFLUENCE OF HEIGHT ON QUANTITATIVE SENSORY, NERVE-CONDUCTION, AND CLINICAL INDEXES OF DIABETIC PERIPHERAL NEUROPATHY [J].
GADIA, MT ;
NATORI, N ;
RAMOS, LB ;
AYYAR, DR ;
SKYLER, JS ;
SOSENKO, JM .
DIABETES CARE, 1987, 10 (05) :613-616
[3]   Reliability and Validity of a Point-of-Care Sural Nerve Conduction Device for Identification of Diabetic Neuropathy [J].
Lee, Justin A. ;
Halpern, Elise M. ;
Lovblom, Leif E. ;
Yeung, Emily ;
Bril, Vera ;
Perkins, Bruce A. .
PLOS ONE, 2014, 9 (01)
[4]   Pro198Leu missense polymorphism of the glutathione peroxidase 1 gene might be a common genetic predisposition of distal symmetric polyneuropathy and macrovascular disease in Japanese type 2 diabetic patients [J].
Matsuno, Shohei ;
Sasaki, Hideyuki ;
Yamasaki, Hiroshi ;
Yamaoka, Hiroyuki ;
Ogawa, Kenichi ;
Nakatani, Muneki ;
Hamanishi, Tohru ;
Doi, Asako ;
Nakano, Yoshio ;
Wakasaki, Hisao ;
Furuta, Hiroto ;
Nishi, Masahiro ;
Akamizu, Takashi ;
Nanjo, Kishio .
JOURNAL OF DIABETES INVESTIGATION, 2011, 2 (06) :474-482
[5]   Quantitative assessment of chemotherapy-induced peripheral neurotoxicity using a point-of-care nerve conduction device [J].
Matsuoka, Ayumu ;
Mitsuma, Ayako ;
Maeda, Osamu ;
Kajiyama, Hiroaki ;
Kiyoi, Hitoshi ;
Kodera, Yasuhiro ;
Nagino, Masato ;
Goto, Hidemi ;
Ando, Yuichi .
CANCER SCIENCE, 2016, 107 (10) :1453-1457
[6]  
Neurometrix, 2013, NC STATR DPNCHECK US
[7]  
Neurometrix, NC STAT DPNCHECK NOR
[8]   DEVELOPING REFERENCE DATA FOR NERVE CONDUCTION STUDIES: AN APPLICATION OF QUANTILE REGRESSION [J].
Peng, Limin ;
Wuu, Joanne ;
Benatar, Michael .
MUSCLE & NERVE, 2009, 40 (05) :763-771
[9]   Multi-site testing with a point-of-care nerve conduction device can be used in an algorithm to diagnose diabetic sensorimotor polyneuropathy [J].
Perkins, Bruce A. ;
Orszag, Andre ;
Grewal, Jaspreet ;
Ng, Eduardo ;
Ngorrt, Mylan ;
Bril, Vera .
DIABETES CARE, 2008, 31 (03) :522-524
[10]   Validation of a novel point-of-care nerve conduction device for the detection of diabetic sensorimotor polyneuropathy [J].
Perkins, Bruce A. ;
Ngo, Mylan ;
Grewal, Jaspreet ;
Ng, Eduardo ;
Bril, Vera .
DIABETES CARE, 2006, 29 (09) :2023-2027